- Home
- AMPS vs PLRX Comparison
AMPS vs PLRX Comparison
Compare AMPS & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPS
- PLRX
- Stock Information
- Founded
- AMPS 2009
- PLRX 2015
- Country
- AMPS United States
- PLRX United States
- Employees
- AMPS N/A
- PLRX N/A
- Industry
- AMPS Electric Utilities: Central
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMPS Utilities
- PLRX Health Care
- Exchange
- AMPS Nasdaq
- PLRX Nasdaq
- Market Cap
- AMPS 608.0M
- PLRX 680.3M
- IPO Year
- AMPS N/A
- PLRX 2020
- Fundamental
- Price
- AMPS $3.96
- PLRX $11.37
- Analyst Decision
- AMPS Strong Buy
- PLRX Strong Buy
- Analyst Count
- AMPS 9
- PLRX 7
- Target Price
- AMPS $5.38
- PLRX $40.50
- AVG Volume (30 Days)
- AMPS 1.1M
- PLRX 485.5K
- Earning Date
- AMPS 03-13-2025
- PLRX 02-26-2025
- Dividend Yield
- AMPS N/A
- PLRX N/A
- EPS Growth
- AMPS N/A
- PLRX N/A
- EPS
- AMPS 0.22
- PLRX N/A
- Revenue
- AMPS $185,992,000.00
- PLRX N/A
- Revenue This Year
- AMPS $30.74
- PLRX N/A
- Revenue Next Year
- AMPS $17.00
- PLRX N/A
- P/E Ratio
- AMPS $17.86
- PLRX N/A
- Revenue Growth
- AMPS 25.90
- PLRX N/A
- 52 Week Low
- AMPS $2.71
- PLRX $10.22
- 52 Week High
- AMPS $7.28
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- AMPS 51.87
- PLRX 44.60
- Support Level
- AMPS $3.60
- PLRX $10.35
- Resistance Level
- AMPS $4.14
- PLRX $11.07
- Average True Range (ATR)
- AMPS 0.26
- PLRX 0.61
- MACD
- AMPS 0.02
- PLRX 0.06
- Stochastic Oscillator
- AMPS 70.53
- PLRX 43.50
About AMPS Altus Power Inc.
Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.